Skip to main content
. 2017 Mar 10;8(19):31215–31226. doi: 10.18632/oncotarget.16107

Table 1. Basic characteristics of involved individuals in the serum study.

Health patients /BPH (N = 51) PCa (N = 98) P value
Age 67.63 ± 5.03 67.83 ± 4.82 0.81
PSA 2.18 ± 2.42 35.94 ± 99.31 0.001**
fPSA /PSA 0.40 ± 0.49 0.07 ± 0.07 < 0.001**
BMI 22.07 ± 1.18 22.05 ± 1.11 0.94
BG 5.43 ± 0.32 5.27 ± 0.47 0.01*
SP 125.63 ± 13.26 127.51 ± 12.78 0.40
DP 79.02 ± 10.19 77.95 ± 10.11 0.54
CHO 3.98 ± 0.77 4.71 ± 0.92 0.01*
TG 1.44 ± 0.79 1.57 ± 0.73 0.63
LDL 2.59 ± 0.63 3.18 ± 0.63 0.01*
HDL 1.16 ± 0.31 1.12 ± 0.43 0.73
FFA 0.38 ± 0.15 0.35 ± 0.13 0.46
OT 31.31 ± 13.34 37.53 ± 9.18 0.005**